Overview

Bioequivalence Study of Two Treatments in the Treatment of Inflammatory Lesions of Rosacea on the Face

Status:
Completed
Trial end date:
2017-10-01
Target enrollment:
Participant gender:
Summary
To compare the bioequivalence of Perrigo's azelaic acid foam product to Finacea Foam for the treatment of Inflammatory Lesions of Rosacea
Phase:
Phase 3
Details
Lead Sponsor:
Padagis LLC
Perrigo Company
Collaborator:
DPT Laboratories, Ltd.
Treatments:
Azelaic acid